Categories Cancer

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research NEW YORK–(BUSINESS WIRE)–Volastra Therapeutics today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit. […]

Read More
Categories Cancer

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF …

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF … [unable to retrieve full-text content] This review article focuses on the use of infectious bacteria as delivery tool for tumour necrosis factor alpha, a well-studied cytokine, in the context of …Published at Tue, 06 Apr 2021 11:15:14 +0000

Read More
Categories Multiple Myeloma

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory …

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory … – MitoImmune initiates a Phase 2 trial of oral mucositis (OM) prevention in the first half of 2021 in the US and Korea, and is expanding OM treatment into hematopoietic stem cell transplantation clinical trials SEOUL, South Korea, April 6, 2021 /PRNewswire/ […]

Read More
Categories Multiple Myeloma

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor In a cohort of patients with monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma, whole-genome sequencing (WGS) identified disease-defining genomic events that successfully identified 2 distinct precursors of multiple myeloma that may be able to stratify individuals as having either progressive or stable disease entities.1 […]

Read More